Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 12 of 12 entries
View as:

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Phase: N/A Priority: Normal
NCT ID: NCT02434276 Org: User:
Start: 05/31/15 End: 06/30/16 Due: 06/30/17

Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00966238 Org: User:
Start: 09/30/09 End: 03/31/11 Due: 03/31/12

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Phase: N/A Priority: Normal
NCT ID: NCT02015494 Org: User:
Start: 03/31/14 End: 12/31/15 Due: 12/31/16

Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01172054 Org: User:
Start: 07/31/10 End: 11/30/11 Due: 11/30/12

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

Phase: N/A Priority: Normal
NCT ID: NCT01658800 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00921947 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00921973 Org: User:
Start: 06/30/09 End: 09/30/09 Due: 09/30/10

Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00603811 Org: User:
Start: 09/30/07 End: 10/31/08 Due: 10/31/09

Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00730457 Org: User:
Start: 07/31/08 End: 06/30/09 Due: 06/30/10

Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00921206 Org: User:
Start: 06/30/09 End: 12/31/09 Due: 12/31/10

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Phase: N/A Priority: Normal
NCT ID: NCT02247362 Org: User:
Start: 11/30/14 End: 03/31/16 Due: 03/31/17

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Phase: N/A Priority: Normal
NCT ID: NCT01560793 Org: User:
Start: 06/30/12 End: 11/30/13 Due: 11/30/14